FOUNTAIN PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: H81644 | EPSOM, KT17 1TG
Showing results 51-100 of 530
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Finasteride | 511 | 22.3K | £785 | -22.0% ▼ |
| Other emollient preparations | 510 | 297.1K | £4.1K | -15.1% ▼ |
| Carbocisteine | 501 | 102.2K | £3.7K | -6.2% ▼ |
| Doxycycline hyclate | 499 | 5,153 | £508 | -2.7% ▼ |
| Donepezil hydrochloride | 496 | 20.9K | £9.9K | +60.7% ▲ |
| Cetirizine hydrochloride | 494 | 47.7K | £2.7K | -1.1% vs avg |
| Fluticasone propionate (Inhalation) | 493 | 749 | £15.9K | +27.4% ▲ |
| Famotidine | 485 | 23.2K | £12.8K | -0.6% vs avg |
| Indapamide | 476 | 22.0K | £1.0K | -44.8% ▼ |
| Allopurinol | 473 | 28.0K | £596 | -54.1% ▼ |
| 470 | 82.7K | £2.8K | -0.9% vs avg | |
| Bendroflumethiazide | 468 | 22.8K | £365 | -39.5% ▼ |
| Rosuvastatin calcium | 465 | 22.9K | £881 | -48.2% ▼ |
| Edoxaban | 458 | 21.1K | £35.1K | -34.6% ▼ |
| Progesterone | 450 | 46.0K | £8.8K | +7.5% ▲ |
| Linagliptin | 447 | 17.9K | £20.2K | +9.1% ▲ |
| Latanoprost | 440 | 9,543 | £3.0K | -9.4% ▼ |
| Isosorbide mononitrate | 430 | 21.4K | £2.9K | -34.9% ▼ |
| Warfarin sodium | 430 | 28.3K | £916 | -8.8% ▼ |
| Diclofenac diethyl | 414 | 47.4K | £3.4K | +16.6% ▲ |
| 411 | 883 | £31.5K | -24.6% ▼ | |
| Hydrocortisone | 402 | 11.7K | £2.4K | -10.3% ▼ |
| Rivaroxaban | 400 | 25.4K | £13.2K | -34.6% ▼ |
| Ferrous fumarate | 391 | 39.0K | £1.6K | -46.1% ▼ |
| Quetiapine | 389 | 21.2K | £11.6K | -37.5% ▼ |
| Lactulose | 381 | 185.0K | £1.7K | +15.7% ▲ |
| Sitagliptin | 381 | 18.5K | £1.7K | -2.3% ▼ |
| Diazepam | 370 | 7,586 | £179 | -25.7% ▼ |
| Ezetimibe | 366 | 18.5K | £3.3K | -48.6% ▼ |
| Insulin aspart | 360 | 2,292 | £14.6K | -5.5% ▼ |
| Betamethasone valerate | 346 | 26.1K | £2.1K | -10.1% ▼ |
| 345 | 43.9K | £1.3K | +24.8% ▲ | |
| 341 | 3,745 | £1.2K | +36.7% ▲ | |
| Lamotrigine | 334 | 29.3K | £4.2K | -43.4% ▼ |
| Clarithromycin | 330 | 8,394 | £1.7K | +34.5% ▲ |
| Methotrexate | 327 | 7,336 | £4.5K | +0.5% vs avg |
| Mesalazine (Systemic) | 324 | 48.9K | £24.8K | +35.3% ▲ |
| Spironolactone | 323 | 12.1K | £2.0K | -40.1% ▼ |
| Sildenafil (Erectile Dysfunction) | 319 | 1,896 | £260 | -36.7% ▼ |
| Venlafaxine | 312 | 14.5K | £3.0K | -63.1% ▼ |
| Hydroxocobalamin | 307 | 373 | £808 | -36.2% ▼ |
| Insulin glargine | 305 | 1,539 | £15.7K | +7.4% ▲ |
| Alginic acid compound preparations | 302 | 149.8K | £2.1K | -48.4% ▼ |
| Desogestrel | 301 | 33.5K | £1.7K | -24.1% ▼ |
| Melatonin | 300 | 17.1K | £2.2K | -9.8% ▼ |
| Sumatriptan succinate | 298 | 3,402 | £2.5K | -15.9% ▼ |
| Estriol | 295 | 5,636 | £3.3K | +38.6% ▲ |
| Gabapentin | 291 | 36.7K | £2.6K | -70.9% ▼ |
| Lercanidipine hydrochloride | 289 | 15.3K | £1.4K | -53.2% ▼ |
| Montelukast | 285 | 13.2K | £687 | -58.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.